Federal grants to J.david Gladstone Institutes
J.david Gladstone Institutes in San Francisco, California received $224 million in federal grants from fiscal 2021 to 2025, across 135 awards. Its largest program was Aging Research, with $77.9 million. In fiscal 2025 it was awarded $49.5 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$224 million
- Awards135
- Awarded in FY 2025$49.5 million
- Largest award$27.3 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 56 | $43.8 million |
| FY 2022 | 61 | $47.2 million |
| FY 2023 | 52 | $40.9 million |
| FY 2024 | 49 | $42.2 million |
| FY 2025 | 59 | $49.5 million |
Programs that fund J.david Gladstone Institutes
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 38 | $77.9 million |
| Allergy and Infectious Diseases Research | 13 | $46.2 million |
| Cardiovascular Diseases Research | 17 | $26.7 million |
| Trans-NIH Research Support | 10 | $16.1 million |
| Drug Use and Addiction Research Programs | 8 | $15.4 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 15 | $12.1 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 3 | $6.2 million |
| Military Medical Research and Development | 4 | $5.3 million |
| Mental Health Research Grants | 3 | $4.3 million |
| Cancer Biology Research | 3 | $3.6 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 125 | $215 million |
| Department of Defense | 4 | $5.3 million |
| National Science Foundation | 6 | $3.2 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Hope - HIV obstruction by programmed epigenetics - project summary/abstact after 40 years, a cure for people living with HIV (PLWH) remains both elusive and one of niaid/nih’s highest priorities. Rebound-competent latent reservoir cells persist despite antiretroviral therapy and rekindle infection d | Allergy and Infectious Diseases Research | August 13, 2021 | $27.3 million |
| Decoding the multifactorial etiology of neural network dysfunction in alzheimer's disease - supplement – summary tau contributes to alzheimer’s disease (AD) and many other brain diseases. However, it is uncertain how tau causes neuronal dysfunction and degeneration, in part because experimental mode | Aging Research | August 4, 2021 | $23.4 million |
| Combinatorial regulation of gene networks during cardiac development and disease | Cardiovascular Diseases Research | August 19, 2021 | $8.2 million |
| Vascular-immune mechanisms of cerebral amyloid angiopathy and alzheimer's pathology - cognitive decline in the aging brain is driven by overlapping neurodegenerative and cerebrovascular pathologies. Over 80% of alzheimer's disease (AD) patients co-present with cerebral amyloid angiopathy (CAA), the | Aging Research | September 19, 2024 | $5.4 million |
| Sorting and sequencing latent reservoirs in HIV+ opioid users - abstract opioid users are prime beneficiaries of cure strategies for HIV due to their medical and social vulnerabilities and low adherence to antiretroviral therapies, but the nature of the latent reservoir in people using morphine or h | Drug Use and Addiction Research Programs | September 15, 2023 | $4.7 million |
| A gene drive therapy for HIV: single-administration intervention for high-risk groups | Drug Use and Addiction Research Programs | March 25, 2021 | $4.6 million |
| Neurovascular interactions: mechanisms, imaging, therapeutic potential | Extramural Research Programs in the Neurosciences and Neurological Disorders | August 31, 2021 | $4.2 million |
| Neuronal apoe drives selective neurodegeneration in alzheimer's disease - project summary selective neurodegeneration is a critical causal factor in alzheimer’s disease (AD); however, the mechanisms that lead some neurons to perish while others remain resilient are unknown. There is regional suscept | Aging Research | July 29, 2021 | $4.1 million |
| Develop ad connectivity maps with human ipsc-derived brain cells and their use - summary alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder caused by interactions among multiple genetic and environmental factors. The strongest genetic factor of ad is apolipoprotein (APO) e genot | Aging Research | August 18, 2022 | $3.7 million |
| Transforming HIV vaccine design with a hybrid technology that leverages features of mrna and protein nanoparticle platforms - proposal summary/abstract the HIV-1/AIDS epidemic continues to affect ~40 million people globally, yet there is still no effective vaccine largely due to HIV-1’S enormous gen | Allergy and Infectious Diseases Research | September 26, 2025 | $3.6 million |
Questions people ask
How much federal grant money does J.david Gladstone Institutes get?
$224 million in 135 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives J.david Gladstone Institutes the most?
The Department of Health and Human Services, with $215 million in 125 awards. The Department of Defense and the National Science Foundation follow.
What is J.david Gladstone Institutes's largest federal grant?
$27.3 million under Allergy and Infectious Diseases Research, with its first action in the period on August 13, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund J.david Gladstone Institutes?
Its largest are Aging Research, Allergy and Infectious Diseases Research and Cardiovascular Diseases Research.
Other grant recipients in San Francisco
- The Regents of the University of California, San Francisco
- California Public Utilities Commission
- City & County of San Francisco
- City & County of San Francisco
- Golden Gate Bridge, Highway & Transportation District
- City and County of San Francisco
- Wested
- San Francisco State University
Largest federal grant recipients in California · Federal grants in California